#Biopharmaceutics Services India

[global-research-report]

CDMOs in the Spotlight: Revolutionizing the Production of Active Pharmaceutical Ingredients

The global active pharmaceutical ingredient CDMO market size was valued at USD 193.7 billion in 2030 and is projected to grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2030. Increasing pharmaceutical R&D investments, patent expirations, and a rise in demand for generic drugs and biologic innovations propelling outsourcing are the factors driving the market.

The growth of small molecules, rising active pharmaceutical ingredient (API) complexity and the need to reduce costs are factors contributing to the rapid expansion of outsourcing services in the pharmaceutical sector. Only a few companies have achieved global reach and scale in the contract development and manufacturing organization (CDMO) sector, which is still fragmented. Besides, many companies are providing one-stop-shop solutions as an integrated source of APIs and formulations.

As the healthcare industry is undergoing a process of dynamic change, factors such as rapid technological advancements (e.g., automation & AI), the need for CROs/CMOs/CDMOs, and rising investments in research are influencing the healthcare market. The outsourcing of activities is benefitting many pharmaceutical companies in improving their operational efficiencies, expanding their geographical presence, decreasing resource costs, gaining therapeutic expertise, and enhancing on-demand services.

The COVID-19 pandemic placed unprecedented expectations on API makers, as evidenced by the substantial increase in demand for medications required to manage critically ill patients on mechanical ventilation. As a result, the sudden need to rapidly increase production has emphasized the need for adaptability for API CDMOs in maintaining drug supply, with some companies proving to be better prepared to withstand the pressures of quick scale-up than others. Growing demand for new therapies worldwide and an increase in the conduction of clinical research in the post-pandemic period are expected to support the market in the coming years.

Active Pharmaceutical Ingredient CDMO Market Report Highlights

The traditional active pharmaceutical ingredient segment dominated the market and accounted for the largest revenue share of 39.8% in 2023, due to the high adoption of traditional API in majority of pharmaceuticals

The innovative drugs segment held 73.7% of the revenue share in 2023. This is largely attributed to increasing FDA approvals for new molecular entities, and the increased focus on R&D by innovator API companies

The oncology segment led the market with the highest revenue share of 35.5% in 2023. This is due to the increasing demand for highly potent APIs for cancer therapy

The biotech segment is expected to grow at the fastest rate of 7.0% over the forecast period, owing to the high adoption of biopharmaceuticals in the treatment of chronic and infectious diseases

The clinical workflow segment is anticipated to witness the fastest CAGR of 7.3% over the forecast period. An increase in the number of clinical research studies supporting the demand for APIs is one of the key factors driving segment growth

In Asia Pacific, the market is expected to register the fastest CAGR of 9.1% over the forecast period. Due to the extreme growth in the number of pharmaceutical companies and contract manufacturing organizations in developing countries such as India and China, the region is likely to overtake Europe and North America in the near future

Active Pharmaceutical Ingredient CDMO Market Segmentation

Grand View Research has segmented the global Active Pharmaceutical Ingredient CDMO market report on the basis of product, synthesis, drug, application, workflow, and region:

API CDMO Product Outlook (Revenue, USD Million, 2018 - 2030)

Traditional Active Pharmaceutical Ingredient (Traditional API)

Highly Potent Active Pharmaceutical Ingredient (HP-API)

Antibody Drug Conjugate (ADC)

Others

API CDMO Synthesis Outlook (Revenue, USD Million, 2018 - 2030)

Synthetic

Biotech

API CDMO Drug Outlook (Revenue, USD Million, 2018 - 2030)

Innovative

Generics

API CDMO Workflow Outlook (Revenue, USD Million, 2018 - 2030)

Clinical

Commercial

API CDMO Application Outlook (Revenue, USD Million, 2018 - 2030)

Oncology

Hormonal

Glaucoma

Cardiovascular disease

Diabetes

Others

API CDMO Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

China

India

Japan

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Colombia

Chile

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players

Cambrex Corporation

Recipharm AB

Thermo Fisher Scientific Inc. (Pantheon)

CordenPharma International

Samsung Biologics

Lonza

Catalent, Inc.

Siegfried Holding AG

Piramal Pharma Solutions

Boehringer Ingelheim International GmbH

Order a free sample PDF of the Active Pharmaceutical Ingredient CDMO Market Intelligence Study, published by Grand View Research.

[datastringconsulting]

Breaking Down the $2.8 billion Membrane Chromatography Demand: Top 5 Consuming Countries in Focus

Industry revenue for Membrane Chromatography is expected to rise to $6.8 billion by 2030 from $2.8 billion of 2024. The revenue growth of industry players is estimated to average at 15.7% annually for period 2024 to 2030. Growing end-industries in major countries like U.S., Germany and Japan, is driving the market demand towards short-term peak; and with such a growth trajectory, Membrane Chromatography's from raw materials suppliers to end-user industries is expected to evolve & shift towards integration. Recent market developments indicate that leading market players are making the strategic market advancements in frontier markets including Brazil, India and South Africa.

Industry Leadership and Strategies

Companies such Sartorius AG, Danaher Corporation, Merck Millipore, Thermo Fisher Scientific, 3M Company, Asahi Kasei Corporation, Cole-Parmer Instrument Company LLC, Bio-Rad Laboratories Inc, GE Healthcare, Pall Corporation, Novasep Holding and Membrane Solutions LLC are well placed in this market’s competition, which is intensely competitive at application scale.

Industry Transitions

The market for Membrane Chromatography has been greatly influenced by the pharmaceutical industrys transition to manufacturing practices which improves production efficiency and reduces waste while also enhancing product quality. Factors that directly affect the need for membrane chromatography solutions due to their crucial role, in this manufacturing process.

The fast expansion of the industry has brought about a new era of change for the Membrane Chromatography market. Biopharmaceutical products necessitate advanced purification techniques to guarantee their effectiveness and safety when used. This has led to a rise in the need, for membrane chromatography methods as they provide a solution to address this issue.

Access report details here - https://datastringconsulting.com/industry-analysis/membrane-chromatography-market-research-report

Bout Datastring Consulting

DataString Consulting offers a complete range of market research and business intelligence solutions for both B2C and B2B markets all under one roof. We offer bespoke market research projects designed to meet the specific strategic objectives of the business. DataString’s leadership team has more than 30 years of combined experience in Market & business research and strategy advisory across the world. DataString Consulting’s data aggregators and Industry experts monitor high growth segments within more than 15 industries on an ongoing basis.

DataString Consulting is a professional market research company which aims at providing all the market & business research solutions under one roof. Get the right insights for your goals with our unique approach to market research and precisely tailored solutions. We offer services in strategy consulting, comprehensive opportunity assessment across various sectors, and solution-oriented approaches to solve business problems.

[snehalblog]

Bioprocess Bags Market: Innovations Driving Growth in Biopharmaceutical Production- UnivDatos

According to a new report by UnivDatos Market Insights, the Bioprocess Bags Market was valued at approximately USD 3.85 Billion in 2023 and is expected to grow at a substantial CAGR of around 17.5% during the forecast period (2024-2032) owing to the increased demand for biologics and biosimilars. The growth of the bioprocess bags market reflects the global trend towards the usage of single-use technologies in biopharmaceutical production. These industries avail themselves by minimized lead time, decreased probability of contamination, and improved production. The bioprocess bags market expansion is fueled by the increasing need for biologics, biosimilars, and vaccines. In October 2022, Austrian solution provider Single Use Support GmbH expanded its product portfolio with new single-use bioprocess containers under the brand name IRIS. The pioneering company leverages its know-how to provide reliable process solutions in the field of biopharmaceutical fluid management, continuing to pursue its vendor-agnostic approach.

Request To Download Sample of This Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=68909&utm_source=LinkSJ&utm_medium=Snehal&utm_campaign=Snehal&utm_id=snehal

Segments that transform the industry

·         Based on product type, the market is segmented into single-use bioprocessing bags and multi-use bioprocessing bags. Single-use bioprocessing bags held a significant share of the market in 2023 owing to enhanced growth by facilitating rapid production scaling, the need to clean them less often, and possessing lower risk of cross-contamination. Adding to this, companies use these bags in bioprocessing due to their adaptability to bioprocesses such as media preparation, mixing, and product storage. Their adaptability to automated bioreactors and closed systems makes them fundamental to the current biomanufacturing industry. For instance, on March 28, 2022 — ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced its launch of liquid single-use bioprocessing bags, representing the first of many new products for handling and supply of sterile liquids for the biotherapeutics market. This expansion is a continuation of ILC Dover’s solution set across the entire biotherapeutic and pharmaceutical manufacturing workflow, from powder containment and handling, through sterile liquid handling and pre-filled liquid and powder bags.

According to the report, the impact of Bioprocess Bags has been identified to be high for the Asia-Pacific area.

For More Informative Information, Please Visit Us- https://univdatos.com/get-a-free-sample-form-php/?product_id=68909&utm_source=LinkSJ&utm_medium=Snehal&utm_campaign=Snehal&utm_id=snehal

Some of how this impact has been felt include:

Asia-Pacific is expected to grow with a significant CAGR during the forecast period (2024-2032). This is due to the booming biotechnology industry and rapidly growing consumption of biopharma products in the region’s emerging giants such as China and India. It is one of the most important bioprocessing locations because government policies support the production of local goods along with cheaper manufacturing expenses. Increased spending on single-use technologies and increasing outsourcing of CMC services through more CMOs/CROs are critical drivers. There are several reasons companies opt for bioprocess bags compliance with international quality standards and the need to scale up biosimilars and vaccine production. The region’s emphasis on new technologies and export-oriented biomanufacturing also drives adoption even more.

On June 1, 2021, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it has acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

[businessitblog]

Top MNC Companies in Pune

Pune, the cultural capital of Maharashtra, has emerged as a key hub for multinational corporations (MNCs) in India. The city's growing infrastructure and well-educated workforce have attracted many MNCs across various sectors such as IT, automotive, finance, manufacturing, and pharmaceuticals. 

In this article, we will delve into some of the top MNC companies in Pune, their key features, ratings, and how to apply for jobs in these companies at different levels, from entry-level to senior positions.

Explore top companies 

1. Infosys Technologies

Industry: IT Services Key Features:

Infosys is a leading provider of IT consulting and services, offering solutions to clients globally.

The company provides a wide range of services, including digital transformation, cloud computing, and AI.

Infosys places a strong emphasis on employee development with regular training programs and career growth opportunities. Rating: 4.2/5 (Glassdoor)

How to Apply:To apply for a job at Infosys, visit their careers page, where you can search for job openings based on job functions, locations, and experience levels. For senior roles, applicants need to submit detailed CVs, followed by interviews.

2. Cognizant Technology Solutions

Industry: IT and Consulting Key Features:

Cognizant offers digital and technology solutions globally, specializing in software engineering, data analytics, and consulting.

The company is known for its work culture, employee satisfaction, and high-performance standards.

It provides opportunities in various fields including engineering, IT, and business consulting. Rating: 4.0/5 (Glassdoor)

How to Apply:You can apply for positions at Cognizant by visiting their career page, where you can filter vacancies by domain and location. Candidates generally go through an online assessment followed by technical and HR interviews.

3. Tata Consultancy Services (TCS)

Industry: IT and Consulting Key Features:

TCS is one of the largest IT services providers in India, specializing in consulting, software development, and digital transformation.

The company offers various career development and upskilling programs.

TCS is renowned for its work-life balance and employee benefits. Rating: 4.1/5 (Glassdoor)

How to Apply:You can apply to TCS via their recruitment portal, where you need to submit an application. The process includes an online test followed by a technical interview and HR interview. TCS also recruits from colleges for entry-level positions.

4. Siemens India

Industry: Engineering and Technology Key Features:

Siemens is a global leader in electrical engineering and electronics, specializing in automation, digitalization, and electrification.

Known for its innovative technologies and sustainable practices.

Offers careers in engineering, IT, and project management. Rating: 4.3/5 (Glassdoor)

How to Apply:Job vacancies at MNC companies in pune Siemens are listed on their career page. For mid-management roles, applicants submit resumes and undergo online tests. Senior roles require direct applications, references, and experience verification.

5. Pfizer India

Industry: Pharmaceuticals Key Features:

Pfizer is a global leader in biopharmaceuticals, focusing on oncology, immunology, and rare diseases.

The company is known for its research and development initiatives in the pharmaceutical sector.

Roles available include R&D, marketing, sales, and regulatory affairs. Rating: 4.2/5 (Glassdoor)

How to Apply:Visit Pfizer’s career portal to apply for jobs in your preferred domain. Entry-level roles generally require a basic qualification and an online application, while senior positions require industry experience and leadership skills.

6. HDFC Bank

Industry: Banking and Financial Services Key Features:

HDFC Bank is one of India's largest private sector banks, offering a range of banking services to individuals and businesses.

Known for its enthusiastic corporate culture and competitive pay scales.

Offers opportunities in finance, customer service, operations, and digital banking. Rating: 4.1/5 (Glassdoor)

How to Apply:HDFC Bank's career page allows you to apply for positions across various domains. Applicants for mid-management roles submit resumes, followed by aptitude tests and interviews. Senior positions involve formalized application procedures and interview rounds.

7. Accenture

Industry: Consulting and IT Services Key Features:

Accenture is a leader in consulting, technology services, and outsourcing.

Offers a wide range of opportunities in strategy, consulting, technology, and operations.

Known for its training programs and career growth prospects. Rating: 4.3/5 (Glassdoor)

How to Apply:To apply to MNC companies in Pune at  Accenture, visit their career portal and submit applications for open positions. Entry-level roles involve a technical interview, while senior roles require case studies and leadership discussions.

8. Capgemini

Industry: IT and Consulting Key Features:

Capgemini is a global IT services and consulting company, providing technology-driven business solutions.

Known for its inclusive work culture, diversity, and employee well-being.

Offers roles in IT, consulting, and business transformation. Rating: 4.0/5 (Glassdoor)

How to Apply:Apply through Capgemini's website, where you can search for jobs. Entry-level candidates must pass online tests followed by interviews. Senior positions require knowledge of business processes and relevant industry experience.

9. L'Oréal India

Industry: Cosmetics and Beauty Key Features:

L'Oréal is a leader in beauty and cosmetics, known for innovation and strong brands.

Offers career opportunities in product development, marketing, and sales.

Famous for nurturing creativity and talent development. Rating: 4.2/5 (Glassdoor)

How to Apply:Visit L'Oréal's careers page to apply for jobs in product development, marketing, or sales. Entry-level applicants submit resumes, while senior candidates must demonstrate experience and industry knowledge.

10. IBM India

Industry: IT and Consulting Key Features:

IBM is a global technology company known for its cloud computing and AI services.

Renowned for its innovative solutions and inclusive work culture.

Offers a comprehensive learning and development program. Rating: 4.1/5 (Glassdoor)

How to Apply:Job seekers can apply via IBM’s career website. Entry-level candidates must pass an online test, followed by technical and HR interviews. Senior roles require an updated CV, leadership experience, and high-level technical skills.

Application Process in MNCs from Entry-Level to Senior Positions

Entry-Level Positions:

For entry-level roles, applicants generally need a relevant degree or certification. The application process involves submitting a resume through the company’s career portal or job board. Candidates may need to take an online aptitude test, followed by interviews.

Mid-Level Jobs:

For mid-level roles, candidates need 3-5 years of relevant experience. The application process typically includes submitting a resume and going through detailed interviews, which may include technical tests or case studies. Leadership potential and industry experience are highly valued.

Senior-Level Jobs:

Senior roles require extensive experience, often 5-10 years. Applicants must submit an updated CV that highlights leadership roles and achievements. The process usually involves multiple interview rounds, including discussions on strategy, leadership, and industry expertise.

Conclusion

Pune offers a thriving ecosystem for MNC companies in Pune, providing numerous job opportunities across industries like IT, finance, healthcare, automotive, and cosmetics.

Whether you're starting your career or looking for a more senior role, the city has options at every level. By following the application processes outlined by these top companies, you can find a role that aligns with your skills and career goals.

[sudheervanguri]

Syngene Fresher SAS Programmers | Bangalore - Exciting Career Opportunity Are you a recent graduate passionate about SAS programming? Syngene International, a leading global biopharmaceutical services provider, is hiring Fresher SAS Programmers in Bangalore. This is an excellent opportunity for fresh talent to launch their career in the dynamic field of clinical research and data analysis. SAS Programmer Job Openings at Syngene About Syngene International Syngene International is a top-tier global contract research organization that delivers high-quality services in drug discovery and development. Headquartered in Bangalore, Syngene is at the forefront of the pharmaceutical and biotech industry, offering cutting-edge solutions to some of the world’s leading pharmaceutical companies. Working at Syngene means being part of a vibrant, diverse, and innovative environment. Role Overview As a SAS Programmer, you will be responsible for generating and preparing SAS data sets for statistical analysis. Your key tasks will include transforming raw data into meaningful information, creating SDTM and ADaM datasets, and generating tables, listings, and graphs for various clinical research projects. This is an ideal role for fresh graduates with a keen interest in data programming and clinical research. Key Responsibilities Developing the data sets from raw data. Generation of SAS data sets for statistical analysis, Tables and Listings in a standard format. Participate in project related meetings. Responsible for creation of SDTM and ADaM data sets. Perform quality checks on the data or deliverables. Preparing of tables, listing and graphs, as applicable [caption id="attachment_111330" align="aligncenter" width="930"] Syngene Fresher SAS Programmers | Bangalore[/caption] Qualifications Required The ideal candidate should meet the following qualifications: Education: A Bachelor’s degree or higher in Life Sciences, Computer Science, Statistics, or related fields. Experience: 0-3 years of experience in SAS programming, particularly in clinical research or statistical analysis. Freshers with a strong understanding of SAS are also encouraged to apply. Application Details Job Location: Bangalore, India Position: SAS Programmer Job ID: 1232270100 Experience: 0-3 Years How to Apply: Interested candidates can apply through the Syngene career portal at the link below. Apply Here

[latestmarketresearchnews]

Pharmaceutical Packaging Market 2030 Top Key Players, Trends, Share, Industry Size, Segmentation

The global pharmaceutical packaging market was valued at USD 139.37 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2030. This growth is largely driven by the rapid expansion of the pharmaceutical industry, which has been advancing due to scientific and technological innovations. The ongoing growth is expected to continue, especially in developing regions such as China, India, Saudi Arabia, and Brazil, where healthcare infrastructure and demand for medicines are expanding significantly.

In 2023, the United States represented the largest pharmaceutical market globally. Several factors contribute to this, including a well-established healthcare system, high per capita income, and substantial investments in research and drug development. The increasing focus on generic drugs and the improvement in healthcare services are expected to provide promising opportunities for the pharmaceutical packaging market. Notably, the 21st Century Cures Act (Cures Act), signed in 2016, is aimed at accelerating medical product development in the U.S., thus fostering innovation in the pharmaceutical industry. This legislation is anticipated to boost demand for pharmaceutical packaging by supporting the launch of new and innovative drug formulations.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Packaging Market

Europe’s pharmaceutical sector is one of its high-performing and technologically advanced industries, significantly contributing to the regional economy. The sector is evolving with an increased focus on developing biopharmaceutical drugs, which has grown over recent years. Many biotechnology-based drug therapies are sensitive to degradation and thus require specialized packaging, such as lyophilized or dry powder forms, to maintain stability. This demand for sophisticated packaging solutions is creating new growth opportunities for packaging manufacturers.

Pharmaceutical products are primarily available in forms such as tablets, capsules, liquids, and powders. They require various packaging solutions, including rigid bottles, stand-up pouches, flat pouches, sachets, and blister packs, each designed to meet specific needs. Packaging companies are now prioritizing features like dispensing aids, administration tools, eco-friendly materials, tamper-evident seals, and anti-counterfeiting measures to enhance product safety, accessibility, and sustainability.

End-use Segmentation Insights:

The pharma manufacturing segment was the largest end-use segment in 2023, accounting for a 49.9% market share, and is anticipated to see strong growth through to 2030. This trend is primarily due to the rising demand for medicines worldwide. According to the World Health Organization (WHO), the global population aged over 60 is expected to nearly double from 12% in 2015 to 22% by 2050, increasing the need for medicines and healthcare. The aging population requires more medical assistance, which is driving pharmaceutical production and, subsequently, the demand for pharmaceutical packaging.

To manage costs and increase efficiency, pharmaceutical companies are increasingly outsourcing packaging activities. By outsourcing, companies can avoid investing directly in packaging materials and equipment, instead working with specialized contractors who provide efficient packaging solutions. This shift is expected to fuel demand for contract manufacturing and pharmaceutical packaging equipment.

Retail pharmacies, especially in developing countries like India, China, and Brazil, are using branding on packaging materials such as polybags and paper pouches to differentiate their products. As retail penetration expands in these regions, the retail pharmacy segment is likely to see significant growth.

Institutional pharmacies, which operate within healthcare facilities like hospitals, nursing homes, and assisted living communities, are expected to grow as well. The increasing number of hospitals and healthcare facilities, along with rising healthcare expenditures, is likely to drive demand for pharmaceutical packaging in this segment. With a growing focus on healthcare accessibility and quality, the institutional pharmacy end-use sector is anticipated to contribute significantly to the overall growth of the pharmaceutical packaging market.

Order a free sample PDF of the Pharmaceutical Packaging Market Intelligence Study, published by Grand View Research.

[researchreportinsight]

Pharmaceutical Packaging Market 2030 Driving Factors, Future Trends, Size & Key Vendors

The global pharmaceutical packaging market was valued at USD 139.37 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2030. This growth is largely driven by the rapid expansion of the pharmaceutical industry, which has been advancing due to scientific and technological innovations. The ongoing growth is expected to continue, especially in developing regions such as China, India, Saudi Arabia, and Brazil, where healthcare infrastructure and demand for medicines are expanding significantly.

In 2023, the United States represented the largest pharmaceutical market globally. Several factors contribute to this, including a well-established healthcare system, high per capita income, and substantial investments in research and drug development. The increasing focus on generic drugs and the improvement in healthcare services are expected to provide promising opportunities for the pharmaceutical packaging market. Notably, the 21st Century Cures Act (Cures Act), signed in 2016, is aimed at accelerating medical product development in the U.S., thus fostering innovation in the pharmaceutical industry. This legislation is anticipated to boost demand for pharmaceutical packaging by supporting the launch of new and innovative drug formulations.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Packaging Market

Europe’s pharmaceutical sector is one of its high-performing and technologically advanced industries, significantly contributing to the regional economy. The sector is evolving with an increased focus on developing biopharmaceutical drugs, which has grown over recent years. Many biotechnology-based drug therapies are sensitive to degradation and thus require specialized packaging, such as lyophilized or dry powder forms, to maintain stability. This demand for sophisticated packaging solutions is creating new growth opportunities for packaging manufacturers.

Pharmaceutical products are primarily available in forms such as tablets, capsules, liquids, and powders. They require various packaging solutions, including rigid bottles, stand-up pouches, flat pouches, sachets, and blister packs, each designed to meet specific needs. Packaging companies are now prioritizing features like dispensing aids, administration tools, eco-friendly materials, tamper-evident seals, and anti-counterfeiting measures to enhance product safety, accessibility, and sustainability.

End-use Segmentation Insights:

The pharma manufacturing segment was the largest end-use segment in 2023, accounting for a 49.9% market share, and is anticipated to see strong growth through to 2030. This trend is primarily due to the rising demand for medicines worldwide. According to the World Health Organization (WHO), the global population aged over 60 is expected to nearly double from 12% in 2015 to 22% by 2050, increasing the need for medicines and healthcare. The aging population requires more medical assistance, which is driving pharmaceutical production and, subsequently, the demand for pharmaceutical packaging.

To manage costs and increase efficiency, pharmaceutical companies are increasingly outsourcing packaging activities. By outsourcing, companies can avoid investing directly in packaging materials and equipment, instead working with specialized contractors who provide efficient packaging solutions. This shift is expected to fuel demand for contract manufacturing and pharmaceutical packaging equipment.

Retail pharmacies, especially in developing countries like India, China, and Brazil, are using branding on packaging materials such as polybags and paper pouches to differentiate their products. As retail penetration expands in these regions, the retail pharmacy segment is likely to see significant growth.

Institutional pharmacies, which operate within healthcare facilities like hospitals, nursing homes, and assisted living communities, are expected to grow as well. The increasing number of hospitals and healthcare facilities, along with rising healthcare expenditures, is likely to drive demand for pharmaceutical packaging in this segment. With a growing focus on healthcare accessibility and quality, the institutional pharmacy end-use sector is anticipated to contribute significantly to the overall growth of the pharmaceutical packaging market.

Order a free sample PDF of the Pharmaceutical Packaging Market Intelligence Study, published by Grand View Research.

[marketanalysisdata]

Pharmaceutical Packaging Market Analysis Report - Industry Trends, Growth and Segmentation 2030

In 2023, the global pharmaceutical packaging market reached a valuation of USD 139.37 billion and is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2030. This growth is largely driven by the rapid expansion of the pharmaceutical industry, which has seen significant advancements in science and technology in recent years. These advancements are anticipated to continue driving demand, especially in emerging markets like China, India, Saudi Arabia, and Brazil, where pharmaceutical production and healthcare services are expanding rapidly.

The United States holds the largest pharmaceutical market share worldwide. Key factors behind this include the nation’s extensive healthcare infrastructure, high per capita income, and significant investments in drug research and development. The rise in generic drugs and improved access to healthcare services in the U.S. are also expected to create promising opportunities for pharmaceutical packaging over the coming years. Additionally, the 21st Century Cures Act (Cures Act), signed into law on December 13, 2016, was enacted to accelerate the development and approval of medical products, encouraging innovations that are anticipated to drive demand for pharmaceutical packaging in the U.S.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Packaging Market

In Europe, the pharmaceutical industry is a crucial component of the economy and is one of the region's most high-performing and technologically advanced sectors. Recent years have seen a significant shift toward the development of biopharmaceutical drugs, a focus that has grown substantially. Biopharmaceuticals often require specialized packaging, as many biotechnology-derived drug therapies are unstable in liquid form and are instead offered as lyophilized (freeze-dried) or dry powder formulations. These specialized dosage forms demand advanced packaging solutions to maintain the drugs' stability and efficacy, creating new opportunities for packaging manufacturers to innovate.

The pharmaceutical packaging market is diverse and fragmented, featuring large and medium-sized international companies alongside smaller domestic players. Key players in this market include Amcor plc, Becton, Dickinson and Company, AptarGroup, Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, O-I Glass, Inc., SGD Pharma, West Pharmaceutical Services, Inc., Berry Global Group, Inc., WestRock Company, International Paper, Comar, LLC, CCL Industries, and Vetter Pharma International.

Product Segmentation Insights:

Pharmaceutical packaging is categorized into three main types: primary, secondary, and tertiary packaging. In 2023, primary packaging accounted for the largest share of the market. Primary packaging refers to materials such as bottles, tubes, and blister packs that come into direct contact with the drug, protecting it from contamination and aiding in safe storage. Primary packaging often also plays a role in dispensing and dosing, and manufacturers are focusing on user-friendly designs, including easy-open closures and dispensing systems that ensure the correct dose is given at the appropriate time. These advancements are especially beneficial for elderly populations, who may need additional support in handling medication.

Secondary pharmaceutical packaging is the next layer of protection, grouping multiple primary packages to safeguard them from external impacts. This packaging is critical for both branding and logistics. It not only helps protect the drug but also serves as a marketing tool by displaying the product in an attractive way. Secondary packaging also makes it easier to handle and transport multiple units, which is important for distribution efficiency.

Tertiary packaging, on the other hand, is used to wrap or bundle large groups of products, facilitating safe handling and transportation of goods across long distances. Examples of tertiary packaging include brown cardboard boxes, shrink wraps, and plastic bags. The growth of e-pharmacy (online pharmaceutical sales) has contributed to the increased need for tertiary packaging, as it ensures the safe and efficient transport of pharmaceutical products directly to consumers. This trend is expected to further drive demand for tertiary packaging over the forecast period.

Order a free sample PDF of the Pharmaceutical Packaging Market Intelligence Study, published by Grand View Research.

[marketstudyreport]

Pharmaceutical Packaging Market Overview, Challenges and Growth Opportunities Analysis till 2030

In 2023, the global pharmaceutical packaging market reached a valuation of USD 139.37 billion and is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2030. This growth is largely driven by the rapid expansion of the pharmaceutical industry, which has seen significant advancements in science and technology in recent years. These advancements are anticipated to continue driving demand, especially in emerging markets like China, India, Saudi Arabia, and Brazil, where pharmaceutical production and healthcare services are expanding rapidly.

The United States holds the largest pharmaceutical market share worldwide. Key factors behind this include the nation’s extensive healthcare infrastructure, high per capita income, and significant investments in drug research and development. The rise in generic drugs and improved access to healthcare services in the U.S. are also expected to create promising opportunities for pharmaceutical packaging over the coming years. Additionally, the 21st Century Cures Act (Cures Act), signed into law on December 13, 2016, was enacted to accelerate the development and approval of medical products, encouraging innovations that are anticipated to drive demand for pharmaceutical packaging in the U.S.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Packaging Market

In Europe, the pharmaceutical industry is a crucial component of the economy and is one of the region's most high-performing and technologically advanced sectors. Recent years have seen a significant shift toward the development of biopharmaceutical drugs, a focus that has grown substantially. Biopharmaceuticals often require specialized packaging, as many biotechnology-derived drug therapies are unstable in liquid form and are instead offered as lyophilized (freeze-dried) or dry powder formulations. These specialized dosage forms demand advanced packaging solutions to maintain the drugs' stability and efficacy, creating new opportunities for packaging manufacturers to innovate.

The pharmaceutical packaging market is diverse and fragmented, featuring large and medium-sized international companies alongside smaller domestic players. Key players in this market include Amcor plc, Becton, Dickinson and Company, AptarGroup, Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, O-I Glass, Inc., SGD Pharma, West Pharmaceutical Services, Inc., Berry Global Group, Inc., WestRock Company, International Paper, Comar, LLC, CCL Industries, and Vetter Pharma International.

Product Segmentation Insights:

Pharmaceutical packaging is categorized into three main types: primary, secondary, and tertiary packaging. In 2023, primary packaging accounted for the largest share of the market. Primary packaging refers to materials such as bottles, tubes, and blister packs that come into direct contact with the drug, protecting it from contamination and aiding in safe storage. Primary packaging often also plays a role in dispensing and dosing, and manufacturers are focusing on user-friendly designs, including easy-open closures and dispensing systems that ensure the correct dose is given at the appropriate time. These advancements are especially beneficial for elderly populations, who may need additional support in handling medication.

Secondary pharmaceutical packaging is the next layer of protection, grouping multiple primary packages to safeguard them from external impacts. This packaging is critical for both branding and logistics. It not only helps protect the drug but also serves as a marketing tool by displaying the product in an attractive way. Secondary packaging also makes it easier to handle and transport multiple units, which is important for distribution efficiency.

Tertiary packaging, on the other hand, is used to wrap or bundle large groups of products, facilitating safe handling and transportation of goods across long distances. Examples of tertiary packaging include brown cardboard boxes, shrink wraps, and plastic bags. The growth of e-pharmacy (online pharmaceutical sales) has contributed to the increased need for tertiary packaging, as it ensures the safe and efficient transport of pharmaceutical products directly to consumers. This trend is expected to further drive demand for tertiary packaging over the forecast period.

Order a free sample PDF of the Pharmaceutical Packaging Market Intelligence Study, published by Grand View Research.

[riverxlabn]

Peptide manufacturing companies in india

Provides complete clinical development services to its global biopharmaceutical clients to speed up and guarantee that the medication approval process will proceed as planned. Typically, contract research has a clear goal and frequently requires results, like item reports or distributions. We make intermediates of high quality at reasonable prices without sacrificing quality. We give our regulatory clients all the paperwork they need to fill out their forms. As a result of our awareness of its significance, we have already filed secondary advanced intermediates to assist our clients in clearing their documents as quickly as possible. We are determined to supply pharmaceuticals of superior quality in accordance with industry standards and manufacturing intermediates. Experts in their fields Our group of experts is made up of experts with a lot of experience who are well-prepared to constantly come up with new ideas and put them into action so that we can produce and sell intermediates at a good price.

retaining a prominent position in the pharmaceutical manufacturing sector in the face of ever-changing and expanding demands for high-quality production through cutting-edge developments and skilled researchers.

[harshnews]

Protein Engineering Market Size, Share, Trends, Growth Opportunities, Key Drivers and Competitive Outlook

"Global Protein Engineering Market – Industry Trends and Forecast to 2029

Global Protein Engineering Market, By Product (Instruments, Reagents, Service and Software), Technology (Rational Protein Design, Irrational Protein Design), Protein Type (Monoclonal Antibodies, Insulin, Erythropoietin, Interferon, Colony Stimulating Factor, Growth Hormones, Coagulation Factor, Vaccines, Others), End-Users (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029

Access Full 350 Pages PDF Report @

**Segments**

- **Product**: The product segment in the protein engineering market includes instruments, reagents, and services. Instruments consist of protein analyzers, Chromatography, Mass Spectrometers, and X-ray Crystallography. Reagents include antibodies, protein labelling, and purification kits. Services include protein sequencing, protein engineering, and protein design. - **Technology**: The technology segment comprises rational protein design, directed evolution, and hybrid technology. Rational protein design involves the use of computational models to design proteins with specific functions. Directed evolution uses iterative rounds of mutation and selection to optimize protein properties. Hybrid technology combines aspects of rational design and directed evolution for protein engineering. - **Application**: Protein engineering finds applications in therapeutics, diagnostics, and industrial processes. In therapeutics, engineered proteins are utilized for drug development, targeted therapy, and personalized medicine. In diagnostics, proteins are used as biomarkers for disease detection and monitoring. In industrial processes, engineered proteins enhance the efficiency of biocatalysts, enzymes, and biosensors.

**Market Players**

- **Thermo Fisher Scientific**: A leading player in the protein engineering market, Thermo Fisher Scientific provides a comprehensive range of instruments, reagents, and services for protein analysis and engineering. The company's advanced technologies and global presence position it as a key player in the market. - **Merck KGaA (EMD Millipore)**: Merck KGaA offers a diverse portfolio of protein engineering tools, including reagents for protein purification, expression systems, and analytics. The company's strong focus on innovation and R&D drives its presence in the protein engineering market. - **Agilent Technologies**: Agilent Technologies is known for its high-quality instruments and solutions for protein analysis and engineering. The company's cutting-edge technologies and broad customer base contribute to its significant market share. - **Bio-Rad Laboratories**: Bio-Rad Laboratories specializes in protein analysis and purification products, serving researchers in academic, biopharmaceutical,Bio-Rad Laboratories has established itself as a prominent player in the protein engineering market due to its extensive range of high-quality protein analysis and purification products. The company's offerings cater to a diverse customer base, including researchers in academic institutions, biopharmaceutical companies, and clinical diagnostics laboratories. Bio-Rad's innovative solutions enable efficient protein characterization, quantification, and purification, essential processes in protein engineering. The company's strong reputation for reliability and accuracy in protein analysis has solidified its position as a trusted provider of tools and reagents for protein research and development.

Bio-Rad Laboratories' commitment to research and development is a key driver of its success in the protein engineering market. The company invests heavily in cutting-edge technology and product innovation to meet the evolving needs of the industry. By continuously introducing new and improved solutions for protein analysis and purification, Bio-Rad stays ahead of the competition and maintains its relevance in the market. This focus on R&D not only enhances the company's product portfolio but also reinforces its reputation as a leader in protein engineering technology.

Furthermore, Bio-Rad Laboratories' strategic partnerships and collaborations with academic institutions, research organizations, and industry players have contributed to its market influence. By fostering strong relationships with key stakeholders in the protein engineering ecosystem, Bio-Rad gains valuable insights into market trends, customer preferences, and emerging technologies. These partnerships also facilitate knowledge exchange, technology transfer, and co-development efforts that drive innovation and enhance Bio-Rad's competitiveness in the market. Leveraging its network of collaborators, Bio-Rad is well-positioned to capitalize on market opportunities and strengthen its market presence in the protein engineering sector.

In addition to its product offerings and research collaborations, Bio-Rad Laboratories' focus on customer satisfaction and support plays a crucial role in its market success. The company's dedication to providing excellent customer service, technical assistance, and training programs ensures that customers receive the necessary guidance and resources to optimize their protein engineering workflows. By prioritizing customer needs and delivering value-added services**Global Protein Engineering Market Analysis**

- The protein engineering market is driven by the increasing demand for novel protein therapeutics and personalized medicine. As advancements in technology enable more precise protein design and engineering, the market is poised for significant growth in the coming years. - The therapeutics segment dominates the protein engineering market, with engineered proteins playing a crucial role in drug development and targeted therapies. The rising prevalence of chronic diseases and the need for more effective treatments drive the demand for protein therapeutics. - Academic research institutes and pharmaceutical & biotechnology companies are the key end-users of protein engineering tools and services. These institutions and organizations invest heavily in protein research to develop innovative therapies and diagnostic solutions, stimulating market growth. - North America and Europe are the leading markets for protein engineering, owing to the presence of established research institutions, biopharmaceutical companies, and technological advancements. Asia-Pacific is expected to witness significant growth due to increasing R&D activities and investments in the healthcare sector. - Key players in the protein engineering market are focusing on strategic partnerships, acquisitions, and product launches to expand their market presence and cater to evolving customer needs. R&D investments and technological innovations remain critical for sustaining competitiveness in the market.

The global protein engineering market is witnessing steady growth driven by advancements in technology, increasing demand for personalized medicine, and the growing focus on protein-based therapeutics. The market is segmented based on products, technologies, protein types, end-users, and geography. In terms of products, instruments, reagents, and

Key points covered in the report: -

The pivotal aspect considered in the global Protein Engineering Market report consists of the major competitors functioning in the global market.

The report includes profiles of companies with prominent positions in the global market.

The sales, corporate strategies and technical capabilities of key manufacturers are also mentioned in the report.

The driving factors for the growth of the global Protein Engineering Market are thoroughly explained along with in-depth descriptions of the industry end users.

The report also elucidates important application segments of the global market to readers/users.

This report performs a SWOT analysis of the market. In the final section, the report recalls the sentiments and perspectives of industry-prepared and trained experts.

The experts also evaluate the export/import policies that might propel the growth of the Global Protein Engineering Market.

The Global Protein Engineering Market report provides valuable information for policymakers, investors, stakeholders, service providers, producers, suppliers, and organizations operating in the industry and looking to purchase this research document.

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Global Protein Engineering Market Landscape

Part 04: Global Protein Engineering Market Sizing

Part 05: Global Protein Engineering Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

The investment made in the study would provide you access to information such as:

Protein Engineering Market [Global – Broken-down into regions]

Regional level split [North America, Europe, Asia Pacific, South America, Middle East & Africa]

Country-wise Market Size Split [of important countries with major market share]

Market Share and Revenue/Sales by leading players

Market Trends – Emerging Technologies/products/start-ups, PESTEL Analysis, SWOT Analysis, Porter’s Five Forces, etc.

Market Size

Market Size by application/industry verticals

Market Projections/Forecast

Browse Trending Reports:

10g Substrate Materials Market Cloud Application Programming Interface Api And Management Platforms And Middleware Market Abscisic Acid Aba Market Benign Mesonephroma Market Cancer Supportive Care Products Market Data Center Interconnect Market Potash Fertilizers Market Private Label Food And Beverage Market Relational Database Market Commercial Lighting Market Ethoxylates Market Eclinical Solutions Market Vaccines Market Spark Plug Market High Visibility Clothing Market Gas Turbine Services Market Dessert Mix Market Lipid Nutrition Market Barrier Films Flexible Electronics Market Nasal Polyposis Drugs Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[umadeochake]

Biopharmaceutical Third-Party Logistics Market Size, Regional Revenue and Outlook 2025-2037

The report on Biopharmaceutical Third-Party Logistics Market, encapsulates an in-depth analysis of the vast space of the business sphere. The report features a summary of the industry that includes a snapshot of the business ecosystem, as well as the summary of the market segmentation. The report is also inclusive of the company profiles, not to mention, the product details, production capabilities, the valuation held, and trends. In the light of the prominent competitors in the market, the report encompasses at a minimum, a brief analysis of the competitive dashboard of the leading players, with emphasis on the presence of the various service providers, the diverse product range of manufacturer offerings, as well as the end-to-end production capabilities.

Request Free Sample Copy of this Report @ https://www.researchnester.com/sample-request-6463

Market Segmentation

Segment 1: Service Type

Description of characteristics and demographics of this segment.

Explanation of why this segment is important in the Biopharmaceutical Third-Party Logistics Market.

Segment 2: Supply chain

Description of characteristics and demographics of this segment.

Explanation of why this segment is important in the Biopharmaceutical Third-Party Logistics Market.

Regional Analysis

North America

Market Trend: The Biopharmaceutical Third-Party Logistics Market in North America is experiencing steady growth, driven by the increasing demand for Biopharmaceutical Third-Party Logistics Market products and services.

Market Opportunity: There is a significant opportunity for Biopharmaceutical Third-Party Logistics Market companies to expand their presence in North America by targeting specific industries and regions.

Europe

Market Trend: The Biopharmaceutical Third-Party Logistics Market in Europe is highly competitive, with a focus on innovation and technological advancements.

Market Opportunity: European countries offer a strong customer base and a supportive business environment for Biopharmaceutical Third-Party Logistics Market companies to thrive.

Request for customization @ https://www.researchnester.com/customized-reports-6463

Asia-Pacific

Market Trend: The Biopharmaceutical Third-Party Logistics Market in Asia-Pacific is experiencing rapid growth, fueled by the increasing adoption of Biopharmaceutical Third-Party Logistics Market products and services in emerging economies.

Market Opportunity: Asia-Pacific presents a vast market opportunity for Biopharmaceutical Third-Party Logistics Market companies, particularly in countries like China and India.

Latin America

Market Trend: The Biopharmaceutical Third-Party Logistics Market in Latin America is growing steadily, driven by the rising disposable income and changing consumer preferences.

Market Opportunity: Latin American countries offer untapped potential for Biopharmaceutical Third-Party Logistics Market companies to expand their market presence and cater to the evolving needs of the population.

In a nutshell, the Biopharmaceutical Third-Party Logistics Market analysis report is an inherent collection of the market definitions, industry insights, and the overall scope of the report. Information about the numerous industry pitfalls and challenges, in addition to driving parameters influencing the revenue scale of this business, have also been provided in the report.

Access our detailed report @ https://www.researchnester.com/reports/biopharmaceutical-third-party-logistics-market/6463

About Research Nester-

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[industrynewsupdates]

Pharmaceutical Packaging Market Segmentation and Competitive Analysis Report 2024-2030

The global pharmaceutical packaging market size was valued at USD 139.37 billion in 2023 and is expected to grow a compound annual growth rate (CAGR) of 9.7% from 2024 to 2030.

The enormous growth of the pharmaceutical sector is one of the primary growth factors for the pharmaceutical packaging sector. The pharmaceutical business has been expanding quickly in recent years due to scientific and technological advancements, and this trend is predicted to continue over the projection period, particularly in developing nations like China, India, Saudi Arabia, and Brazil.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Packaging Market

The U.S. accounted for the largest pharmaceutical market worldwide. Large healthcare system, high per capita income, and large investments in drug development in the country are some of the key factors driving the U.S. market. Furthermore, growing importance of generic drugs and access to better healthcare services are anticipated to provide lucrative opportunities for pharmaceutical packaging in the coming years. The 21st Century Cures Act (Cures Act) was signed on December 13, 2016, in the U.S. and is designed to accelerate medical product development. The law is expected to drive new innovations in product developments in pharmaceutical industry. This is expected to drive the demand for pharmaceutical packaging in U.S.

The pharmaceutical industry is primarily driven by the progress in the field of medicine and bioscience. In addition, pharmaceutical industry acts as a key asset to the European economy as it is one of the Europe’s top-performing, high-technology sectors. Pharmaceutical industry is witnessing significant transition and focus on the development of biopharmaceutical drugs has considerably grown over the past few years. Few biotechnology-driven drug therapies are unstable in liquid form and are, therefore, introduced as lyophilized or dry powder dosage forms. Lyophilized drugs demand specialized packaging for their optimal performance, resulting in new opportunities for packaging manufacturers.

Pharmaceutical drugs are majorly offered in tablet, capsule, liquid, and powder forms. Various packaging types, including rigid bottles, standup pouches, flat pouches, sachets, and blister packs, are used for their packaging. Packaging companies are increasingly focusing on the incorporation of dispensing mechanisms, administration aids, sustainable material, tamper-evident properties, and counterfeiting measures into the packaging to enhance their functionality and safety.

Companies are majorly focusing on the utilization of post-consumer recycled (PCR) material and are also developing packaging from compostable material to increase the sustainability of packaging. Gerresheimer AG, a leading pharmaceutical packaging manufacturer, has been offering glass bottles made from PCR glass since several years. In addition, the company is offering bottles made from R-PET and BIO-PET (resins made from sugarcane plants). This trend of sustainable packaging is expected to significantly gain pace in the coming years.

One key opportunity lies in developing intelligent packaging technologies that enhance safety, traceability, and patient adherence. Integrating IoT (Internet of Things) devices into packaging can provide real-time monitoring of temperature, humidity, and other critical parameters, ensuring the integrity of pharmaceutical products during storage and transportation. The rise of personalized medicine and specialty drugs also opens opportunities for customized packaging solutions, catering to unique dosages and administration methods. Pharmaceutical companies that can adapt to these trends and offer innovative packaging solutions are well-positioned to thrive in this dynamic market.

Pharmaceutical Packaging Market Segmentation

Grand View Research has segmented the Pharmaceutical Packaging market report on the basis of material, product, drug delivery mode, end-use, and region:

Material Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Plastics & Polymers

o Polyvinyl Chloride (PVC)

o Polypropylene (PP)

o Homo

o Random

o Polyethylene Terephthalate (PET)

o Polyethylene (PE)

o HDPE

o LDPE

o LLDPE

o Polystyrene (PS)

o Others

• Paper & Paperboard

• Glass

• Aluminium Foil

• Others

Product Outlook (Revenue, USD Million, 2018 - 2030)

• Primary

o Plastic Bottles

o Caps & Closures

o Parenteral Containers

o Syringes

o Vials & Ampoules

o Others

o Blister Packs

o Prefillable Inhalers

o Pouches

o Medication Tubes

o Others

• Secondary

o Prescription Containers

o Pharmaceutical Packaging Accessories

• Tertiary

Drug Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)

• Oral Drugs

• Injectables

• Topical

• Ocular/ Ophthalmic

• Nasal

• Pulmonary

• Transdermal

• IV Drugs

• Others

End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharma Manufacturing

• Contract Packaging

• Retail Pharmacy

• Institutional Pharmacy

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o UK

o France

o Italy

o Spain

o Russia

o Turkey

• Asia Pacific

o China

o India

o Japan

o South Korea

o Australia

o Southeast Asia

• Central & South America

o Brazil

o Argentina

• Middle East & Africa

o Saudi Arabia

o UAE

o South Africa

o Egypt

Browse through Grand View Research's Plastics, Polymers & Resins Industry Research Reports.

• The global polycarbonate sheet market size was valued at USD 4.64 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2030.

• The global packaging wax market size was valued at USD 1.95 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2030. 

Key Companies & Market Share Insights

The global market is highly competitive owing to the presence of numerous players across the globe. Moreover, key players are consolidating their market positions mainly by acquisitions, which is further intensifying the competition. Key players directly compete with each other in securing agreements from large-sized pharmaceutical manufacturers. Thus, the competitive rivalry in the global market is observed to be high.

Players are focusing on offering value-added services to attract a greater number of clients. Spray painting, ultraviolet coating, and metallization are the commonly employed processes for coloring packaging containers that are used by packaging manufacturers. In addition, labeling and the incorporation of various anti-counterfeit packaging measures, including overt and covert technologies, such as barcodes, holograms, sealing tapes, and radio frequency identification devices, are often undertaken by the packaging manufacturers.

• In November 2023, Amcor Plc, a renowned global company known for its development and production of environmentally conscious packaging solutions, revealed a Memorandum of Understanding (MOU) with NOVA Chemicals Corporate, a leading producer of sustainable polyethylene. The agreement includes the procurement of mechanically recycled polyethylene resin (rPE) from NOVA Chemicals Corporate, which will be utilized in the production of flexible packaging films. This initiative aligns with Amcor's dedication to promoting packaging circularity by increasing the utilization of rPE in flexible packaging applications.

• In July 2023, Constantia Flexibles introduced a new pharmaceutical packaging solution called REGULA CIRC, which utilizes coldform foil. The packaging replaces conventional PVC with a PE sealing layer, resulting in a reduction in plastic content while increasing the proportion of aluminum. This optimization not only enhances the sustainability of the packaging but also improves material recovery during recycling processes.

• In April 2023, Südpack introduced its PharmaGuard blister, a polypropylene-based blister packaging. This new product offers an outstanding water vapor barrier along with effective barrier resistance against UV and oxygen.

Key Pharmaceutical Packaging Companies:

• Amcor plc

• Becton, Dickinson, and Company

• AptarGroup, Inc.

• Drug Plastics Group

• Gerresheimer AG

• Schott AG

• Owens Illinois, Inc.

• West Pharmaceutical Services, Inc.

• Berry Global, Inc.

• WestRock Company

• SGD Pharma

• International Paper

• Comar, LLC

• CCL Industries, Inc.

• Vetter Pharma International

Order a free sample PDF of the Pharmaceutical Packaging Market Intelligence Study, published by Grand View Research.

[shrirampharmacycollege]

Shriram Pharmacy College: Best Pharmacy Education In India

Shriram Pharmacy College, Bankner, stands out as one of India’s premier institutions for pharmacy education. With a strong focus on practical learning, experienced faculty, and state-of-the-art facilities, Shriram Pharmacy College has become synonymous with excellence in pharmacy education. The college offers a comprehensive Bachelor’s program in Pharmacy, covering diverse aspects of the pharmaceutical industry. This blog will explore the key highlights of studying at Shriram Pharmacy College, including career paths, curriculum details, and the unique benefits of choosing this institution.

### 1. **Bachelor’s Program in Pharmacy: A Four-Year Journey to Excellence**

The Bachelor’s program in Pharmacy at Shriram Pharmacy College is a four-year degree program designed to provide students with an in-depth understanding of pharmaceutical sciences. The curriculum is meticulously structured to include theoretical knowledge and practical training, ensuring that students are well-equipped to meet the challenges of the pharmaceutical industry. With a focus on developing technical skills, critical thinking, and ethical practices, the program ensures that graduates are not just academically proficient but also industry-ready professionals.

### 2. **Extensive Training Across Eight Semesters**

The Bachelor of Pharmacy program at Shriram Pharmacy College is spread across eight semesters, each designed to build a strong foundation in core subjects and introduce advanced concepts in pharmaceutical sciences. From pharmacology, medicinal chemistry, and pharmacognosy to biopharmaceutics and clinical pharmacy, the curriculum encompasses all essential topics. Students gain hands-on experience through laboratory sessions, internships, and industry visits, allowing them to apply theoretical knowledge to real-world scenarios and develop critical skills for their future careers.

### 3. **Pharmacy Business: Focus on Customer Service**

One of the critical aspects of pharmacy education at Shriram Pharmacy College is the focus on the pharmacy business and customer service. Students are trained to provide excellent customer service in community and hospital pharmacies, ensuring that they understand the importance of patient care, ethical practices, and communication skills. Courses cover topics such as patient counseling, prescription handling, and customer relationship management, preparing students to excel in pharmacy operations and maintain high standards of care.

### 4. **Hospital Pharmacist: Ensure Accurate Medication Dispensing**

Shriram Pharmacy College places a strong emphasis on training students to become hospital pharmacists, where accuracy in medication dispensing is crucial. The curriculum includes in-depth knowledge of pharmacotherapy, drug interactions, and patient safety protocols. Students learn to work closely with healthcare professionals to ensure patients receive the correct medications and dosages. The practical experience gained through hospital internships and simulation labs helps them understand the complexities of hospital pharmacy and prepares them for a career in healthcare settings.

### 5. **Chemical Technician: Maintain Strict Safety Protocols**

A significant part of the pharmacy education at Shriram Pharmacy College is dedicated to training students as chemical technicians who can work in laboratories and research facilities. The program emphasizes maintaining strict safety protocols, handling chemicals, and using advanced laboratory equipment. Students learn the importance of quality control, analytical testing, and standard operating procedures (SOPs). The hands-on training in state-of-the-art labs ensures that graduates are well-prepared to contribute to the pharmaceutical and chemical industries.

### 6. **Drug Inspector: Conduct Thorough Compliance Checks**

Shriram Pharmacy College prepares its students to pursue careers as drug inspectors, where they are responsible for ensuring that pharmaceutical products meet regulatory standards. The program covers various aspects of drug laws, quality assurance, and regulatory affairs, providing students with the knowledge needed to conduct compliance checks thoroughly. By understanding the regulatory frameworks and industry standards, graduates are equipped to play a vital role in maintaining the quality and safety of pharmaceuticals in the market.

### 7. **Medical Writer: Communicate Complex Information Clearly**

Another career path for graduates of Shriram Pharmacy College is that of a medical writer. The program emphasizes the importance of clear communication, allowing students to convey complex scientific and medical information to various audiences. Courses in technical writing, medical journalism, and content development are integral parts of the curriculum. The training enables graduates to work in research organizations, pharmaceutical companies, and healthcare institutions where effective communication of medical information is essential.

### 8. **Medical Representative: Build Strong Client Relationships**

The Bachelor of Pharmacy program at Shriram Pharmacy College also prepares students to become successful medical representatives who play a crucial role in the pharmaceutical industry. Training focuses on building strong client relationships, understanding product portfolios, and effectively communicating product benefits to healthcare professionals. Students learn the skills needed to thrive in sales and marketing roles, such as persuasive communication, negotiation, and product knowledge, which are vital for success as a medical representative.

### 9. **Unique Benefits of Choosing Shriram Pharmacy College**

Choosing Shriram Pharmacy College for your pharmacy education comes with several unique benefits. The college offers an integrated approach to learning that combines classroom instruction, practical training, and real-world experience. The faculty comprises industry experts and seasoned academicians who provide mentorship and guidance to students. The college also has strong ties with leading pharmaceutical companies and healthcare institutions, facilitating excellent placement opportunities for graduates.

/media/eb0cb48ed6146db932072f4aa2538013

### FAQs

**Q1: What is the duration of the Bachelor of Pharmacy program at Shriram Pharmacy College?**

The Bachelor of Pharmacy program at Shriram Pharmacy College is a four-year degree program, divided into eight semesters. Each semester covers different aspects of pharmaceutical sciences, from fundamental subjects like pharmacology and medicinal chemistry to advanced topics such as clinical pharmacy and drug regulations. The program also includes practical training through lab work, internships, and industry visits, which helps students gain hands-on experience and prepares them for various career opportunities in the pharmaceutical industry.

**Q2: What career opportunities are available after completing a B.Pharm from Shriram Pharmacy College?**

Graduates from Shriram Pharmacy College have a wide range of career opportunities in the pharmaceutical sector. They can work as hospital pharmacists, community pharmacists, drug inspectors, medical writers, chemical technicians, or medical representatives. The comprehensive education provided by the college ensures that students are well-prepared for roles in both clinical and non-clinical settings, research and development, regulatory affairs, and pharmaceutical marketing, among others. The college’s strong industry ties also help in securing placements for graduates.

**Q3: How does Shriram Pharmacy College ensure practical training for its students?**

Shriram Pharmacy College emphasizes practical training through its state-of-the-art laboratories, hands-on workshops, and internships. The college has collaborations with leading pharmaceutical companies and healthcare institutions where students gain real-world experience. Additionally, regular industry visits, guest lectures by professionals, and simulation-based learning modules are integrated into the curriculum. This approach ensures that students are well-equipped with the skills and experience needed to excel in various pharmacy-related roles upon graduation.

**Q4: What makes Shriram Pharmacy College stand out among other pharmacy colleges in India?**

Shriram Pharmacy College stands out due to its commitment to providing a well-rounded pharmacy education. The college offers a robust curriculum that combines theoretical learning with practical application, guided by a team of experienced faculty members. The state-of-the-art facilities, strong focus on research, and industry-oriented training modules further distinguish it from other institutions. Moreover, the college provides excellent placement support and has a track record of producing highly skilled pharmacy professionals who excel in their careers.

**Q5: Are there any research opportunities available for students at Shriram Pharmacy College?**

Yes, Shriram Pharmacy College encourages students to participate in research activities. The college provides opportunities for research in various fields such as pharmacology, medicinal chemistry, and clinical pharmacy. Students can work on innovative projects under the guidance of experienced faculty members, participate in seminars and conferences, and collaborate with industry professionals. These research opportunities not only enhance their learning experience but also prepare them for careers in academia, research, and development sectors.

### **Conclusion**

Shriram Pharmacy College, Bankner, offers a comprehensive and industry-relevant Bachelor of Pharmacy program that equips students with the skills and knowledge needed to excel in the pharmaceutical field. With a curriculum designed to provide both theoretical and practical knowledge, coupled with excellent career support, the college stands as a leading choice for pharmacy education in India. Whether you’re looking to become a pharmacist, a medical writer, or a drug inspector, Shriram Pharmacy College provides the foundation for a successful and rewarding career.

### Stay Connected with Shriram Pharmacy College!

For the latest updates, educational content, and insights into the dynamic field of pharmacy, don’t miss out on the Shriram Pharmacy College YouTube channel. By liking, sharing, and subscribing, you’ll gain access to expert lectures, student testimonials, campus events, and much more. Stay informed about advancements in pharmaceutical sciences and become a part of our vibrant community. Your support helps us grow and continue providing valuable resources to students and professionals alike. Join us today and never miss an update!

[tamanna31]

Pharmaceutical Sterility Testing Market 2024 World Technology, Development, Trends and Opportunities Industry Research Report to 2030

Pharmaceutical Sterility Testing Industry Overview

The global pharmaceutical sterility testing market size was estimated at USD 1.59 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 11.02% from 2024 to 2030.

Increasing government investments, R&D activities, a growing number of drug launches, and a rising focus on quality & sterility are expected to drive the market growth. The development of comprehensive sterility testing procedures is regulated with stringent policies and quality control standards.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Sterility Testing Market

In addition, several government initiatives play a pivotal role in shaping the healthcare landscape, and their financial support significantly influences the development & implementation of advanced sterility testing procedures within the pharmaceutical sector. Increasing government funding for enhanced R&D activities for novel therapeutics, especially vaccines, biologics, and sterile products, which need sterility testing to ensure safety & efficacy. This leads to the introduction of cutting-edge technologies and innovative solutions in the sterility testing market. For instance, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), total healthcare R&D expenditure in the European Union (EU) was around USD 48.5 billion in 2022 compared to USD 46.4 billion in 2021.

Global Pharmaceutical Sterility Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pharmaceutical sterility testing market report based on the type, product type, test type, sample, end-use, and region:

Type Outlook (Revenue, USD Million, 2018 - 2030)

In-House

Outsourcing

Product Type Outlook (Revenue, USD Million, 2018 - 2030)

Kits & Reagents

Instruments

Services

Test Type Outlook (Revenue, USD Million, 2018 - 2030)

Sterility Testing

Membrane Filtration

Direct Inoculation

Product Flush

Bioburden Testing

Bacterial Endotoxin Testing

Rapid Microbial Method

ATP Bioluminescence

Fluorescent -Based

Solid-phase Cytometry

Others

Sample Outlook (Revenue, USD Million, 2018 - 2030)

Pharmaceuticals

Medical Devices

Biopharmaceuticals

End-use Outlook (Revenue, USD Million, 2018 - 2030)

Compounding Pharmacies

Medical Device Companies

Pharmaceutical Companies

Others

Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Netherlands

Switzerland

Sweden

Belgium

Russia

Asia Pacific

Japan

China

India

Australia

South Korea

Philippines

Malaysia

New Zealand

Singapore

Thailand

Latin America

Brazil

Mexico

Argentina

Colombia

Chile

Middle East and Africa (MEA)

South Africa

Saudi Arabia

Egypt

Israel

UAE

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

• The global cancer biopsy market size was valued at USD 30.05 billion in 2023 and is projected to grow at a CAGR of 8.11% from 2024 to 2030.

• The global pediatric cancer biomarkers market size was estimated at USD 815.81 million in 2023 and is projected to grow at a CAGR of 8.5% from 2024 to 2030.

Key Pharmaceutical Sterility Testing Company Insights

Several key players are acquiring various strategic initiatives to strengthen their market position offering diverse services to customers. The prominent strategies adopted by companies are service launches, mergers & acquisitions/joint ventures merger, partnership & agreements, expansions, and others to increase market presence & revenue and gain a competitive edge drives the market growth.

Key Pharmaceutical Sterility Testing Companies:

The following are the leading companies in the pharmaceutical sterility testing market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these pharmaceutical sterility testing companies are analyzed to map the supply network

Pacific Biolabs

Steris Plc

Boston Analytical

Sotera Health Company (Nelson Labs)

Sartorius Ag

Solvias Ag

SGS SA

Labcorp

Pace Analytical

Charles River Laboratories

Thermo Fisher Scientific, Inc.

Rapid Micro Biosystems, Inc.

Almac Group

Labor LS SE & Co. KG

Recent Developments

In January 2024, Rapid Micro Biosystems, Inc. company announced the launch of the Growth Direct Rapid Sterility application by mid-2024

In August 2023, Pace Analytical Services improved its capabilities by adding advanced hydrocarbon analytical support and expanded sediment & tissue testing with the acquisition of Alpha Analytical

In May 2023, Thermo Fisher Scientific, Inc. announced the launch of a sterile drug facility in Singapore. It would help deliver new vaccines and medicines in the Asia Pacific market

Order a free sample PDF of the Pharmaceutical Sterility Testing Market Intelligence Study, published by Grand View Research.